Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-23 · accession 0001822629-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | 2024-03-23 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $69.58 | -17.5K | 394.2K | -4% | -$1.21M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-23 | F | D | 17,455 | $69.58 | 394,174 | D | — | — |